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ABSTRACT
Objectives: The aim of the study was to analyze the origin of birth defects in pregnant women from the Kujawy-Pomerania 
Region, and to identify factors affecting the formation of developmental disorders in the Province. 
Material and methods: The correlation between maternal age and fetal defects was investigated. We also attempted to 
determine whether environmental or family factors play a role in the formation of fetal abnormalities. 
Results: The analysis confirmed a correlation between the incidence of chromosomal aberrations and maternal age.
Conclusions: Higher rates of neural tube defects were observed in fetuses born to mothers who did not take folic acid. 
The influence of other factors on developmental anomalies was not confirmed.
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INTRODUCTION
The beginnings of prenatal diagnostic testing have been 
dated to the fifth century B.C., when Empedocles described 
the fetal membranes surrounding a newborn lamb. In the 
seventeenth century, Francois Mauriceau defined the envi-
ronment where a fetus is developing as a ‘mixture of mater-
nal blood and milk’ and coined the term ‘amniotic fluid’ [1]. 
However, it was not until the twentieth century, during which 
Ian Donald introduced the diagnostic ultrasound and Jerome 
Lejeune linked trisomy 21 with Down’s syndrome, that the 
foundations for the instantaneous development of prenatal 
diagnostic tests were laid. The first prenatal test in Poland was 
performed in 1975. In 1992, Kypros Nicolaides started his re-
search on ultrasound markers of chromosome abnormalities, 
and in 1996 he established the Fetal Medicine Foundation and 
formed a net of cooperating prenatal diagnosis centers. The 
discovery of free fetal DNA in circulating maternal blood 
constituted a breakthrough in contemporary prenatal diag-
nostics. In 2005, studies on new-generation sequencing were 
launched and already in 2008 the first non-invasive prenatal 
test, based on the analysis of fetal DNA, was introduced [2, 3].
OBJECTIVES
The aims of the study were the following:
 Ū determine the cause and incidence of fetal abnormali-
ties diagnosed during the prenatal period in pregnant 
women from the Kujawy-Pomerania Region;
 Ū establish the genetic background of fetal developmen-
tal anomalies;
 Ū identify the nature and distribution of the aberrations;
 Ū select specific predisposing factors for congenital ab-
normalities in the Province.
MATERIAL AND METHODS
A total of 1021 pregnant women, referred to the Genetic 
Clinic of Multi-Specialty County Hospital in Bydgoszcz be-
tween November 2008 and May 2010 to undergo prenatal 
diagnostic tests, were recruited. All patients were admitted 
on the basis of a referral from their ob-gyn in accordance 
with the NHF guidelines for the Prenatal Screening Program 
(PSP). Indications for prenatal testing included: advanced 
maternal age (≥ 35), carriers of chromosome transloca-
tions, family or obstetric history of chromosome abnor-
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malities as well as congenital malformations or genetically 
determined diseases, and suspicion of fetal abnormalities 
in the current pregnancy. Additionally, juvenile patients 
(< 18 years of age) were included with consent of the statu-
tory representative.
A chart of genetic testing was created for all participants 
and detailed medical history (family tree, congenital malfor-
mations, concomitant diseases in the affected women, their 
partners and family members of both parties) was obtained. 
Also, the following environmental factors were analyzed: 
assisted reproduction, occupational hazards, infections, as 
well as stimulant and medicine use.
All study participants underwent an ultrasound exam 
in accordance with the Fetal Medicine Foundation guide-
lines. Next, venous blood was collected for biochemical 
screening tests. Patients with fetal defects diagnosed on 
ultrasound and those at higher risk for fetal aneuploidy in 
biochemical tests underwent amniocentesis after written in-
formed consent was obtained. Ultrasound reevaluation of the 
pregnancy was performed again between 18 and 22 weeks 
of gestation to assess fetal development. If any abnormalities 
were detected, the test was repeated and the patient was re-
ferred to a consultation at a local fetal therapy center. After the 
tests, each patient received a feedback questionnaire about 
further development and course of the pregnancy, possible 
complications, and newborn condition after birth. All patients 
received genetic counselling, including the estimated risk for 
defect reappearance in the subsequent pregnancies. 
RESULTS 
A total of 872 first trimester ultrasound tests (112 abnor-
mal results), 860 first trimester biochemical tests (126 ab-
normal results), 196 triple tests (28 abnormal results), and 
867 second trimester ultrasound tests (73 abnormal results) 
were conducted. Also, 104 invasive procedures were per-
formed, resulting in 28 abnormal results. 
In the study group, 91 congenital defects were found, 
including 25 (27.5%) cases of genetically-determined ab-
normalities, 58 (63.7%) cases without known genetic back-
ground and 8 complex set of defects with undetermined 
genetic background. Out of the genetically-determined ab-
normalities, 80% (20 defects) were chromosome aberrations 
and 20% (5 defects) were monogenic diseases (Tab. 1, 2).
Defects limited to one organ or system constituted the 
largest group, with abnormalities of the Central Nervous 
System (CNS) as the most common (16 patients — 27.6%), 
followed by defects of the skeletal system (12–20.7%), uro-
genital system (10 — 17.2%), heart (8–13.8%), digestive 
system (3–5.1%), and other (9–15.5%) (Fig. 1). 
The most common isolated abnormalities included 
meningocele, hydrocephalus, deformation and defects of 
the limbs, posterior urethral valve, heart defects — mainly 
VSD, ASD, AVSD, abdominal wall defect, cleft lip and cleft 
palate, and cavernous hemangiomas. 
Complex, multi-organ defects of undetermined genetic 
background, including encephalon, heart, chest, and limb 
defects, as well as cleft palate, were found in 8 patients. 
The obtained results were statistically analyzed. 
The relationship between the incidence of fetal defects 
and maternal age was investigated but no correlations be-
tween mean maternal age in the groups with and without 
fetal abnormalities were found. Median age for both groups 
was 32 years (Tab. 3).
Mean maternal age of women with and without chromo-
some aberrations was compared. A correlation between ma-
ternal age and the incidence of chromosome abnormalities 
was confirmed. Mean age in patients with the aberration was 
34 years, i.e. lower than the age threshold for PSP (Tab. 4). 
The effect of environmental factors on the incidence of 
fetal abnormalities was investigated. No statistically signifi-
cant differences between the incidence rates in patients at 
risk and at no risk for harmful environmental factors were 
found. Regardless, slightly higher rates were detected in 
women with positive environmental history (place of work, 
accidental exposure to ionizing radiation, chemicals, and 
plant protection products during pregnancy) (Tab. 5). 
The incidence of fetal defects in women who used fo-
lic acid supplementation was analyzed and compared to 
patients who did not supplement their diet with folic acid. 
Interestingly, the results were similar for both groups (Tab. 6). 
Table 1. Defects with known genetic background 
Genetically determined defects
Chromosomal aberrations (20) Monogenic diseases (5)
Numerical (19) Structural (1) Recessive (2) Dominant (3)
Trisomy 21 (11) 
Trisomy 18 (4) 
Trisomy 13 (1) 
Triploidy (1)
Monosomy X (1) 
Mosaic karyotype 
46,XX/47XXY (1)
Balanced translocation 
46,XY,t(1; 9)
(q32; p22) 
Osseous dysplasia 
SLO syndrome 
Treacher-Collins syndrome
Recklinghausen disease
Ectrodactyly
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Differences in the incidence of CNS defects vs. folic acid 
intake were studied in the group of 91 women who gave 
birth to heathy newborns. No statistically significant dif-
ferences for the level of confidence of 0.05 were observed, 
although a lower rate was detected in women using folic 
acid supplementation (Tab. 7). 
The literature reports a confirmed positive correlation 
between folic acid supplementation and decreased rates 
of CNS defects. In those reports, all pregnant women from 
the population or patients with unremarkable history con-
stituted the control group. In our study, all patients met at 
least one of the PSP criteria. In other words, their medical 
history was not unremarkable and, as such, might have 
differed from the literature data. Thus, the trend persists 
but the obtained results are statistical insignificant [4, 5]. 
DISCUSSION
Genetically-determined diseases have been known for 
centuries and until today they continue to affect popula-
tions all over the world. Delayed motherhood further con-
tributes to the development of chromosome aberrations. At 
least 20% of all fetuses are affected by chromosome abnor-
malities but the vast majority spontaneously abort in the 
early pregnancy. Most fetuses which are miscarried before 
9 weeks of gestation present structural defects [6]. A com-
bined interplay of genetic and environmental factors results 
in the development of fetal abnormalities. All organisms 
are continuously targeted by numerous mutagenic factors 
both, endogenous, formed as a result of metabolic pro-
cesses, and exogenous, resulting from biological, physical, 
and chemical reactions. Exposure of a developing organism 
to harmful agents may lead to a teratogenic effect in the 
form of a congenital defect [7]. It needs to be emphasized 
that our study population included pre-selected pregnant 
women, referred to the Genetic Clinic, in accordance with 
PSP guidelines. All patients met at least one criterion indica-
CNS
Skeletal system
Urogenital system
Heart
Digestive system
Other
27.6%
15.5%
5.1%
13.8%
17.2%
20.7%
Figure 1. Distribution of the isolated defects
Table 3. Correlation between maternal age and incidence of fetal 
abnormalities
Parameters
Subgroups
Defect No defect
N 91 854
Min. 18 16
Max. 45 49
Median 32 32
Mean 32.2 32.0
SD 6.0 5.5
z-test (zcr = 1.96)
z 0.30
p 0.76 
Table 4. Correlation between chromosome abnormalities and 
maternal age 
Age
Parameters
Aberration
Yes No
N 20 71
Min. 21 18
Max. 45 45
Median 33 32
Mean 34.20 31.63
SD 6.98 5.58
Shapiro-Wilk Normality test
W 0.922 –
Wcr 0.905 –
Normality yes –
F Snedecor test (Fcr = 1.93)
F 1.57
p 0.18
t-Student test (tcr = 1.66)
t 1.72
p < 0.05
Table 5. The effect of harmful environmental factors on the incidence of fetal abnormalities 
Fetal defects 
Harmful factors No harmful factors Test for 2 fractions
No. of cases % of cases No. of cases
% 
of cases u p
Yes 11 14.5% 80 9.2%
1.43 0.15
No 65 85.5% 789 90.8%
Total 76 100% 869 100%
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tive of the need for prenatal diagnosis. The incidence of fetal 
abnormalities in our study group has been confirmed to be 
higher as compared to the general population. According to 
the data from the Polish Registry of Developmental Defects, 
congenital defects affect 2–4% of all newborns [8]. Similar 
rates (1.56%) have been reported by E. Kapersky et al. [9]. In 
the studied population, congenital defects were observed 
in 9.6% of the women, with 27.5% genetically-determined, 
63.7% isolated, and 8.8% complex defects with undeter-
mined genetic background. According to the Polish Reg-
istry of Developmental Defects, chromosome aberrations 
account for 6.5% of congenital defects in live newborns, 
with 7.5% of monogenic and 50% of multifactorial abnor-
malities [8]. The incidence of chromosome aberrations in 
our study was significantly higher (2.1%, i.e. 20 defects in 
945 patients) as compared to EUROCAT (30/10000 births) 
and reports of E. Kapersky et al. (10/10000 births) [9, 10]. 
Among the isolated defects, the incidence was as follows: 
CNS (27.6%), skeletal system (20.7%), heart (13.8%), and 
digestive system (5.1%) defects. According to the Pol-
ish Registry of Developmental Defects, the incidence of 
CNS defects between 2005 and 2006 in the regions in-
cluded in the Registry was 15.9/10000 births, followed 
by 70.9/10000 for heart, 42.1/10000 for skeletal system, 
9.3/10000 for the digestive system, and 17.2/10000 for 
complex defects. The incidence of chromosome aberra-
tions was 15.2/10000 births. Data for the entire Province 
included in the Registry are comparable to numbers in the 
Kujawy-Pomerania Region [8]. No statistically significant 
differences were found between mothers from the rural 
areas and inhabitants of big cities, although the incidence 
was higher in the former as compared to the latter (12.2% 
vs. 8.8%, respectively). Kossakowska-Krajewska [11], also 
failed to observe a statistically significant difference be-
tween city and village dwellers, although in her study in-
habitants of urban areas had slightly higher occurrence of 
fetal defects. Antoszewski also analyzed the effect of the 
environment on the development of cleft lip and cleft pal-
ate in the Łódź Region [12]. That study also found no impact 
of maternal place of inhabitance on the type of the cleft 
defect. However, Mejnartowicz, quoting Rull R.P., reports 
a significant effect of parental occupation (agriculture and 
exposure to plant protection products) on the development 
of neural tube defects in the offspring [13].
The study group was investigated for a possible cor-
relation between maternal age and defect incidence. No 
differences were found between mothers of children with 
birth defects and healthy newborns (mean maternal age was 
32.2 and 32 years, respectively). Additionally, age of women 
who gave birth to children with chromosome aberrations 
and those with other defects was compared. The result 
confirmed the role of maternal age in the development of 
chromosome aberrations although mean maternal age in 
that group was 34.2 years. Kossakowska-Krajewska [11], 
reported the highest incidence of congenital abnormalities 
in women over 35 years of age and confirmed the effect of 
advanced maternal age on chromosome aberrations. In yet 
another study [14], the same author emphasized an elevated 
risk for heart and CNS defects in children born to mothers 
under 19 and over 35 years of age.
The role of environmental factors on the development 
of congenital abnormalities has been analyzed. No statisti-
Table 6. The effect of pre-pregnancy folic acid intake on the development of fetal abnormalities
Fetal defects
Pre-pregnancy folic acid intake
Test for 2 fractionsYes No
No. of cases % of cases No. of cases
% 
of cases u p
Yes 32 9.2% 59 10.9%
0.79 0.43
No 315 90.8% 484 89.1%
Total 347 100% 543 100%
Table 7. Correlation between the incidence of CNS and pre-pregnancy folic acid supplementation 
CNS defects
Pre-pregnancy folic acid intake
Test for 2 fractionsYes No
No. of cases % of cases No. of cases
% 
of cases u p
Yes 3 9.4% 13 22.0%
1.62 0.11
No 29 90.6% 46 78.0%
Total 32 100% 59 100%
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cally significant differences for the level of confidence of 
0.05 between endogenous harmful factors and congenital 
defects were observed. Hozyasz described a link between 
cleft lip and cleft palate and parental work environment [15], 
whereas Kossakowska-Krajewska, citing Tesarz, reported no 
correlation between maternal work in the industrial sector 
and the development of the abovementioned defects [14].
Most authors who investigated congenital defects 
focused on their incidence and distribution, or analyzed 
the causes for their occurrence in one organ or system. 
Also, studies on the role of one teratogen in the origin of 
developmental disturbances were conducted or patients 
with a single factor, e.g. diabetes or thyroid disorders, were 
investigated. Out study aimed to identify factors promot-
ing developmental disturbances, regardless of the targeted 
organ or the type of factor. Pregnant women from our study 
population often had several promoting factors, e.g. age, 
harmful work environment, or infection in the early preg-
nancy. Due to the number of potentially teratogenic factors 
and a wide range of conditions, we did not manage to 
establish one unambiguous cause for the development of 
fetal defects in the Kujawy-Pomeranian region. 
CONCLUSIONS
Based on the abovementioned results, it seems safe to 
conclude the following:
 Ū the incidence rates of fetal defects in women referred 
to the Genetic Clinic of Multi-Specialty County Hospital 
in Bydgoszcz were higher as compared to mean rates 
for the Province. Isolated defects are dominant and the 
CNS abnormalities are the most common; 
 Ū in our study, the investigated risk factors had little effect 
on the development of fetal defects; 
 Ū maternal age has a significant influence on the devel-
opment of chromosome aberrations but no correlation 
between age and other fetal abnormalities has been 
detected; 
 Ū in light of the fact that a correlation, at the established 
level of significance, between chromosome aberrations 
and maternal age (median 33 years) was found, it seems 
prudent to liberate current criteria for prenatal diagnos-
tic testing as far as maternal age is concerned. 
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